Braden M Leonard
10% owner at Enliven Therapeutics; 10% owner at Aclaris Therapeutics; 10% owner at AN2 Therapeutics. Based in Zionsville, Indiana.
- Rank
- 7717th of 14,644
- Companies held
- 5
- Largest holding
- ELVN, 89.9% of total
- Latest SEC filing
- Oct 2, 2026
- Listed but not counted
- $171M
What the $11.9M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Enliven Therapeutics ELVN Common Stock | Directly | 230,000 | $46.41 | $10.7M | 89.9% | Form 4/A, Jan 3, 2023 |
| Disc Medicine IRON Common Stock | Directly | 8,250 split-adjusted | $76.11 | $628K | 5.3% | Form 4, Oct 26, 2022 |
| OnKure Therapeutics OKUR Common Stock | Directly | 102,076 | $2.76 | $282K | 2.4% | Form 4, Oct 7, 2024 |
| Retractable Technologies RVP Common Stock | Directly | 387,500 | $0.60 | $232K | 2.0% | Form 4, Dec 29, 2022 |
| Tectonic Therapeutic TECX Common Stock | Directly | 2,778 split-adjusted | $21.04 | $58K | 0.5% | Form 4, Jun 20, 2024 |
Share counts are the amounts Braden M Leonard reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Braden M Leonard's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Enliven Therapeutics ELVN Common Stock | Holding of BML Investment Partners, L.P. Held by a company or fund the insider manages | 1,767,774 | $46.41 | $82.0M | — | Form 4, Jan 4, 2023 |
| Aclaris Therapeutics ACRS Common Stock | Holdings of BML Investment Partners, L.P. Held by a company or fund the insider manages | 13,950,000 | $3.50 | $48.8M | — | Form 4, Apr 23, 2026 |
| AN2 Therapeutics ANTX Common Stock | Holding of BML Investment Partners, L.P. Held by a company or fund the insider manages | 3,217,432 | $5.22 | $16.8M | — | Form 4, May 30, 2025 |
| Disc Medicine IRON Common Stock | Holding of BML Investment Partners, L.P. Held by a company or fund the insider manages | 166,667 split-adjusted | $76.11 | $12.7M | — | Form 4, Oct 26, 2022 |
| Outset Medical OM Common Stock | Holdings of BML Investment Partners, L.P. Held by a company or fund the insider manages | 2,764,610 | $2.91 | $8.0M | — | Form 4, Oct 2, 2026 |
| OnKure Therapeutics OKUR Common Stock | Holding of BML Investment Partners, L.P. Held by a company or fund the insider manages | 345,740 split-adjusted | $2.76 | $954K | — | Form 4, Sep 25, 2024 |
| OnKure Therapeutics OKUR Common Stock | Holdings of BML Investment Partners, L.P. Held by a company or fund the insider manages | 345,739 | $2.76 | $954K | — | Form 4, Oct 7, 2024 |
| Tectonic Therapeutic TECX Common Stock | Holding of BML Investment Partners, L.P, Held by a company or fund the insider manages | 33,363 split-adjusted | $21.04 | $702K | — | Form 4, Jun 20, 2024 |
| Retractable Technologies RVP Common Stock | Holding of BML Investment Partners, L.P. Held by a company or fund the insider manages | 688,575 | $0.60 | $412K | — | Form 4, Dec 29, 2022 |
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 7714 | David Boulette Chief Executive Officer, Eva Live. Las Vegas, NV | $11.9M |
| 7715 | Neena M. Patil EVP & Chief Legal Officer, Jazz Pharmaceuticals | $11.9M |
| 7716 | Michael S. Brown Director, Regeneron Pharmaceuticals. Tarrytown, NY | $11.9M |
| 7717 | Braden M Leonard 10% owner, Enliven Therapeutics. Zionsville, IN | $11.9M |
| 7718 | Mayur Kapani Chief Technology Officer, Intercontinental Exchange. Atlanta, GA | $11.9M |
| 7719 | Mark J. Silk Director, SIFCO Industries. Cleveland, OH | $11.9M |
| 7720 | Daniel M. Sessa EVP, Chief HR Officer, Lennox International. Richardson, TX | $11.9M |
Other Enliven Therapeutics insiders
All ELVN insiders- Mark Chin$109MDirector. #1387 overall
- Joseph P. Lyssikatos$81.3MCHIEF SCIENTIFIC OFFICER. #1764 overall
- Samuel Kintz$41.3MPRESIDENT AND CEO. #2925 overall
- Anish Patel$10.9MCHIEF OPERATING OFFICER. #8209 overall
- David M. Mott$10.6MDirector. #4907 overall
- Richard A. Heyman$6.8MDirector. #9779 overall
Questions
How much stock does Braden M Leonard own?
Braden M Leonard holds $11,874,494 in listed stock based on SEC filings and current prices, mostly Enliven Therapeutics (ELVN). That ranks 7717th on the Stock Rich List.
Is this Braden M Leonard's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Braden M Leonard last buy or sell stock?
The most recent open-market trade on file is a purchase of 16,575 OM shares on Oct 2, 2026 at $3.88.